Premarket Decliner
ARTL Artelo Biosciences4.85-0.94-16.2%
Premarket:3.45-1.40 (-28.9%)
Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments
Globe NewswireWed, 25-Mar 4:05 PM
Premarket Decliner
ARTL Artelo Biosciences8.76-0.29-3.2%
Premarket:6.00-2.76 (-31.5%)
Artelo Biosciences Announces Proposed Underwritten Public Offering
Globe NewswireWed, 3-Sep 4:35 PM
After Hours Decliner
ARTL Artelo Biosciences8.76-0.29-3.2%
After Hours:6.72-2.04 (-23.3%)
Artelo Biosciences Announces Proposed Underwritten Public Offering
Globe NewswireWed, 3-Sep 4:35 PM
After Hours Decliner
ARTL Artelo Biosciences8.76-0.29-3.2%
After Hours:6.72-2.04 (-23.3%)
Artelo Biosciences Announces Proposed Underwritten Public Offering
Globe NewswireWed, 3-Sep 4:35 PM